I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 530.5 ILS -0.92% Market Closed
Market Cap: 255.1m ILS
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+12%
Operating Income
Forecast
+71%
Net Income
Forecast
N/A

Wall Street
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
INCR Lowest Forecast
Wall Street Target
Not Available
INCR Average Forecast
Wall Street Target
Not Available
INCR Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
InterCure Ltd Competitors:
Price Targets
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
50% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
8% Downside
E
ENZY
Enzymatica AB (publ)
3% Downside
GLAND
Gland Pharma Ltd
3% Downside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
50% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
8% Downside
E
ENZY
Enzymatica AB (publ)
3% Downside
GLAND
Gland Pharma Ltd
3% Downside
000538
Yunnan Baiyao Group Co Ltd
28% Upside
C
1093
CSPC Pharmaceutical Group Ltd
11% Upside
PHO
Photocure ASA
57% Upside
P
300363
Porton Pharma Solutions Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
InterCure Ltd

For the last 13 years the compound annual growth rate for InterCure Ltd's revenue is 26%. The projected CAGR for the next 2 years is 55%.

26%
Past Growth
55%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
98%
Average Beat
What are analyst estimates?

See Also

Summary
INCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
INCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INCR stock valuation using valuation multiples.
Wall Street Estimates
INCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCR's stock price target?
Not Available

INCR doesn't have any price targets made by Wall Street professionals.

What is InterCure Ltd's Revenue forecast?
Projected CAGR
55%

For the last 13 years the compound annual growth rate for InterCure Ltd's revenue is 26%. The projected CAGR for the next 2 years is 55%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.